"Morphine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle.
Descriptor ID |
D009020
|
MeSH Number(s) |
D03.132.577.249.562.571 D03.605.497.607.587 D03.633.400.686.607.587 D04.615.723.795.576.571
|
Concept/Terms |
SDZ 202-250- SDZ 202-250
- SDZ 202 250
- SDZ 202250
- SDZ202-250
- SDZ202 250
- SDZ202250
|
Below are MeSH descriptors whose meaning is more general than "Morphine".
Below are MeSH descriptors whose meaning is more specific than "Morphine".
This graph shows the total number of publications written about "Morphine" by people in this website by year, and whether "Morphine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 2 | 1 | 3 |
1995 | 3 | 1 | 4 |
1996 | 3 | 1 | 4 |
1997 | 4 | 2 | 6 |
1998 | 3 | 0 | 3 |
1999 | 5 | 2 | 7 |
2000 | 3 | 2 | 5 |
2001 | 6 | 1 | 7 |
2002 | 2 | 2 | 4 |
2003 | 7 | 1 | 8 |
2004 | 2 | 3 | 5 |
2005 | 7 | 3 | 10 |
2006 | 5 | 3 | 8 |
2007 | 2 | 2 | 4 |
2008 | 5 | 2 | 7 |
2009 | 1 | 0 | 1 |
2010 | 2 | 3 | 5 |
2011 | 1 | 3 | 4 |
2012 | 3 | 2 | 5 |
2013 | 2 | 4 | 6 |
2014 | 6 | 4 | 10 |
2015 | 3 | 1 | 4 |
2016 | 3 | 0 | 3 |
2017 | 1 | 1 | 2 |
2018 | 2 | 3 | 5 |
2019 | 2 | 4 | 6 |
2020 | 3 | 5 | 8 |
2021 | 0 | 3 | 3 |
2022 | 2 | 7 | 9 |
2023 | 0 | 8 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Morphine" by people in Profiles.
-
Surgical transversus abdominis plane block with liposomal bupivacaine at cesarean: a pilot randomized trial. Am J Obstet Gynecol MFM. 2024 Feb; 6(2):101273.
-
Ketamine for Pain in Sickle Cell Disease Reduces Opioid Usage. J Pain Symptom Manage. 2024 Mar; 67(3):e169-e175.
-
Antiemetic prophylaxis with droperidol in morphine-based intravenous patient-controlled analgesia: a propensity score matched cohort study. BMC Anesthesiol. 2023 10 28; 23(1):351.
-
mGluR5 from Primary Sensory Neurons Promotes Opioid-Induced Hyperalgesia and Tolerance by Interacting with and Potentiating Synaptic NMDA Receptors. J Neurosci. 2023 08 02; 43(31):5593-5607.
-
Efficacy and tolerability of oral morphine versus oxycodone/acetaminophen for analgesia in the emergency department. J Opioid Manag. 2023 May-Jun; 19(3):273-280.
-
Do Types of Opioids Matter for Terminal Cancer Dyspnea? A Preliminary Multicenter Cohort Study. J Pain Symptom Manage. 2023 Aug; 66(2):e177-e184.
-
Efforts to Improve Naloxone Co-Prescription for Patients With Cancer Pain at Risk of Opioid Overdose. J Palliat Med. 2023 07; 26(7):969-973.
-
Levorphanol as a Second Line Opioid in Cancer Patients Presenting to an Outpatient Supportive Care Center: An Open-label Study. J Pain Symptom Manage. 2023 06; 65(6):e683-e690.
-
Brief Opioid Exposure Paradoxically Augments Primary Afferent Input to Spinal Excitatory Neurons via a2d-1-Dependent Presynaptic NMDA Receptors. J Neurosci. 2022 12 14; 42(50):9315-9329.
-
a2d-1 protein drives opioid-induced conditioned reward and synaptic NMDA receptor hyperactivity in the nucleus accumbens. J Neurochem. 2023 01; 164(2):143-157.